quipazine has been researched along with s 21007 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caignard, DH; Delagrange, P; Guardiola-Lemaitre, B; Hamon, M; Lancelot, JC; Pfeiffer, B; Prunier, H; Rault, S; Renard, P; Robba, M | 1 |
| Caignard, DH; Delagrange, P; Guardiola-Lemaitre, B; Hamon, M; Lancelot, JC; Misslin, R; Pfeiffer, B; Prunier, H; Rault, S; Renard, P; Robba, M | 1 |
2 other study(ies) available for quipazine and s 21007
| Article | Year |
|---|---|
Novel selective and partial agonists of 5-HT3 receptors. Part 1. Synthesis and biological evaluation of piperazinopyrrolothienopyrazines.
Topics: Animals; Cattle; Choroid Plexus; Frontal Lobe; Hippocampus; In Vitro Techniques; Magnetic Resonance Spectroscopy; Male; Pyrazines; Rats; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Receptor Agonists; Swine | 1996 |
Novel and selective partial agonists of 5-HT3 receptors. 2. Synthesis and biological evaluation of piperazinopyridopyrrolopyrazines, piperazinopyrroloquinoxalines, and piperazinopyridopyrroloquinoxalines.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Cattle; Cell Membrane; Corpus Striatum; Darkness; Frontal Lobe; Guanidine; Guanidines; Hippocampus; Light; Male; Molecular Structure; Pyrazines; Pyridines; Rats; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Receptor Agonists; Structure-Activity Relationship; Swine | 1997 |